Stockscreener 앱 받기
141.44
0.04%
0.07
전일 마감가:
$141.51
열려 있는:
$140.28
하루 거래량:
276.69K
Relative Volume:
0.37
시가총액:
$8.07B
수익:
$633.51M
순이익/손실:
$-8.10M
주가수익비율:
-456.26
EPS:
-0.31
순현금흐름:
$131.26M
1주 성능:
-1.44%
1개월 성능:
+26.46%
6개월 성능:
-3.01%
1년 성능:
-15.26%
1일 변동 폭
$139.68
$143.56
1주일 범위
$132.46
$145.47
52주 변동 폭
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
명칭
Repligen Corp
전화
(781) 449-9560
주소
41 SEYON STREET, WALTHAM, MA
RGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
141.50 | 8.07B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
534.92 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
168.12 | 48.46B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
98.00 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
241.35 | 35.24B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.49 | 16.39B | 3.90B | 392.30M | 288.10M | 1.95 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | 개시 | Evercore ISI | In-line |
| 2025-02-10 | 개시 | TD Cowen | Buy |
| 2024-12-17 | 개시 | Canaccord Genuity | Hold |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-06-18 | 개시 | Guggenheim | Neutral |
| 2023-12-04 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-07-20 | 개시 | Wells Fargo | Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-03-28 | 개시 | The Benchmark Company | Buy |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2021-10-14 | 개시 | Exane BNP Paribas | Outperform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-23 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-11-01 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | 개시 | SVB Leerink | Outperform |
| 2019-08-28 | 재확인 | First Analysis Sec | Outperform |
| 2019-08-23 | 재개 | Stephens | Overweight |
| 2019-07-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | 업그레이드 | CL King | Neutral → Buy |
| 2018-11-12 | 다운그레이드 | CL King | Buy → Neutral |
| 2018-09-26 | 개시 | H.C. Wainwright | Neutral |
| 2017-12-08 | 개시 | Citigroup | Buy |
| 2017-12-05 | 개시 | JP Morgan | Overweight |
| 2017-11-13 | 개시 | CL King | Buy |
| 2017-10-02 | 업그레이드 | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | 개시 | William Blair | Outperform |
| 2017-02-13 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
Repligen Corp 주식(RGEN)의 최신 뉴스
Repligen (RGEN) Maintains Buy Rating with $180 Price Target | RGEN Stock News - GuruFocus
FY2025 EPS Estimates for Repligen Boosted by William Blair - Defense World
Leerink Partnrs Has Pessimistic View of Repligen Q2 Earnings - Defense World
Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare - Insider Monkey
There is no doubt that Repligen Corp (RGEN) ticks all the boxes. - Sete News
Jim Cramer on Repligen Corporation (RGEN): ‘I’m Not Quite Ready to Stick My Neck Out on This One’ - Insider Monkey
Wolfe Research Upgrades Repligen (NASDAQ:RGEN) to “Outperform” - Defense World
BlackRock, Inc. Reduces Stake in Repligen Corp: An In-Depth Anal - GuruFocus
Deep Dive Into Repligen Stock: Analyst Perspectives (8 Ratings) - Benzinga
Wolfe Research Upgrades Repligen Corp (RGEN) to an Outperform from a Peer perform - knoxdaily.com
RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty - Barchart.com
Repligen (RGEN) Price Target Adjusted by RBC Capital Amid Market Trends | RGEN Stock News - GuruFocus
Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com
Repligen Corporation (NASDAQ:RGEN) Q1 2025 Earnings Call Transcript - Insider Monkey
Repligen: Q1 Earnings Snapshot - CT Insider
Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Re - GuruFocus
JPMorgan cuts Repligen stock price target to $190, maintains rating By Investing.com - Investing.com South Africa
Earnings call transcript: Repligen Q1 2025 earnings beat expectations - Investing.com
Jefferies cuts Repligen target to $914, maintains Buy rating - Investing.com
Truist cuts Repligen target to $940, maintains Buy rating - Investing.com
JPMorgan cuts Repligen stock price target to $190, maintains rating - Investing.com
Repligen (RGEN) Target Price Adjusted to $190 by JPMorgan | RGEN Stock News - GuruFocus
Repligen (RGEN) Receives Upgrade from Wolfe Research Following E - GuruFocus
Repligen Corp (NASDAQ: RGEN) Prices Could Soar To Much Higher Levels In Coming Months - Marketing Sentinel
Repligen (RGEN) Achieves Strong Revenue Growth in Q1 | RGEN Stoc - GuruFocus
Repligen Corp’s Market Journey: Closing Weak at 143.63, Down -0.77 - DWinneX
Repligen earnings beat by $0.04, revenue topped estimates - Investing.com
RGEN’s valuation metrics: A comprehensive analysis - uspostnews.com
Repligen Corp Q1 2025 Earnings: Revenue Surpasses Estimates at $169 Million, Adjusted EPS Soars to $0.39 - GuruFocus
What To Expect From Repligen Corp (RGEN) Q1 2025 Earnings - GuruFocus
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations - Yahoo
Repligen Corporation Q1 2025 Financial Results - TradingView
Repligen (NASDAQ:RGEN) Upgraded to “Hold” at StockNews.com - Defense World
Repligen (RGEN) Q1 Earnings: What To Expect - Yahoo Finance
Repligen (RGEN) Projected to Post Earnings on Tuesday - Defense World
Investor’s Delight: Repligen Corp (RGEN) Closes Strong at 141.40, Up 1.78 - DWinneX
A year in review: Repligen Corp (RGEN)’s performance in the last year - uspostnews.com
Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Repligen Corp (NASDAQ: RGEN) Shares Have Loss -0.78% Over The Past Month - Marketing Sentinel
Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Repligen Co. (NASDAQ:RGEN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Cerity Partners LLC Has $613,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen (NASDAQ:RGEN) Cut to “Sell” at StockNews.com - Defense World
Repligen to Report First Quarter 2025 Financial Results - Yahoo Finance
Repligen Corp (RGEN) Shares Up 4.7% on Apr 11 - GuruFocus
Hollow Fiber Filtration Market Future Business Opportunities - openPR.com
Repligen’s 39% decline validates InvestingPro’s bearish Fair Value call By Investing.com - Investing.com India
Repligen's 39% decline validates InvestingPro's bearish Fair Value call By Investing.com - Investing.com
Repligen (RGEN): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com
Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Repligen Corp (RGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Repligen Corp 주식 (RGEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hunt Anthony | Director |
Mar 17 '25 |
Sale |
152.51 |
26,756 |
4,080,663 |
136,301 |
| Pax Margaret | Director |
Mar 17 '25 |
Buy |
150.69 |
250 |
37,672 |
1,043 |
0.67%
0.53%
자본화:
|
볼륨(24시간):